Cantor Fitzgerald Reiterates Neutral on Gilead Sciences, Maintains $80 Price Target
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Olivia Brayer has reiterated a Neutral rating on Gilead Sciences and maintained a price target of $80.
July 24, 2023 | 1:55 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Gilead Sciences' stock rating has been reiterated as Neutral by Cantor Fitzgerald, with a maintained price target of $80.
The reiteration of a Neutral rating indicates that the analyst believes the stock will perform in line with the market average. This is neither a negative nor a positive signal for investors. The maintained price target of $80 suggests that the analyst does not foresee significant price movement in the near term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100